Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04898504
Status:
RECRUITING
Last Update Posted:
2023-08-31
First Post:
2021-05-10
Brief Title:
HAI-Floxuridine or Liver-Tx Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden
Sponsor:
Oslo University Hospital
Organization:
Oslo University Hospital
Organization Data
Organization:
Oslo University Hospital
Class:
OTHER
Study ID:
33572
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oslo University Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Kristoffer Lassen
Responsible Party Title:
Head of department
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Oslo University Hospital
Old Name:
None
Old Organization:
None